Despite endorsed and exponential research to improve diagnostic and therapeutic
strategies, efforts have not yet converted into a better prospect for patients infected with the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of
coronavirus disease 2019 (COVID-19), is a single-stranded RNA virus whose sequence is …

Background Reports of severe COVID-19 being associated with thrombosis,
antiphospholipid antibodies (APLA), and antiphospholipid syndrome have yielded disparate …

Abstract Coronavirus disease 2019 (COVID-19) causes acute microvascular thrombosis in
both venous and arterial structures which is highly associated with increased mortality. The …

Although primarily affecting the respiratory system, COVID-19 causes multiple organ
damage. One of its grave consequences is a prothrombotic state that manifests as …

COVID-19 is currently causing a pandemic around the world. With the increase in the
number of patients, there was a slight increase in the incidence of various complications. In …

Aims Identify the prevalence, risk factors and outcomes of lower extremity ischemic
complications. Methods A systematic review was conducted by searching PubMed and …

The novel coronavirus spread worldwide in 2020, causing millions of deaths and disabilities.
Even though the virus was considered a respiratory virus, its adverse effects can be detected …

Hypercoagulability and vascular injury, which characterize morbidity in COVID-19 disease,
are frequently observed in the skin. Several pathomechanisms, such as inflammation …

The post-COVID neurological syndrome has been coined, which describes the functional
and structural sequelae of coronavirus infection disease-19 (COVID-19) in the brain …